Mary Kearney

Last updated
Mary Kearney
Mary Kearney.jpg
Kearney in 2019
Alma mater Hood College (BA, MS)
Catholic University of America (PhD)
Scientific career
FieldsHIV and translational research
Institutions National Cancer Institute
Thesis HIV-1 evolution in recently infect patients  (2007)
Academic advisors Luke Pallansch
Venigalla B. Rao  [ Wikidata ]
John Coffin

Mary F. Kearney is an American biologist. She is a senior scientist and head of the translational research section in the HIV dynamics and replication program at the National Cancer Institute.

Contents

Education

Kearney completed a B.A. (1996) and M.S. in biomedical science (2001) at Hood College. Her master's thesis was titled Determining the resistance profile of conocurvone, an early-stage inhibitor of HIV-1 replication. Her advisor was Luke Pallansch. [1] Kearney received a Ph.D. in biology from Catholic University of America in 2007 under the direction of John Coffin, Sarah Palmer, and Venigalla B. Rao  [ Wikidata ]. [2]  Her thesis was titled HIV-1 evolution in recently infect patients. [3] She received The Benedict T. DeCicco Award for Excellence in Graduate Research in 2008. [2]  

Career and research

Kearney, Coffin, and colleagues at the 2019 HIV DRP Think Tank Meeting. 2019 HIV DRP Think Tank Meeting.jpg
Kearney, Coffin, and colleagues at the 2019 HIV DRP Think Tank Meeting.

In 2001 she joined the National Cancer Institute's HIV Drug Resistance Program (DRP; renamed the HIV Dynamics and Replication Program in 2015) as a biologist in the virology core. In 2008 she was promoted to head of the translational research section where she oversees a team that investigates HIV genetics and expression in vivo, the sources of persistent viremia during antiretroviral therapy (ART), the sources of rebound viremia after stopping ART, the mechanisms for maintaining the HIV reservoir, and the mechanisms for the emergence of HIV drug resistance mutations. She was a consultant to the World Health Organization from 2010 to 2016, was the keynote speaker for the launch of the Bioinformatics Program at Hood College in 2015 and for the Center for AIDS Research Symposium at the University of Pennsylvania in 2019, and was appointed to the NIH Women Scientist Advisors (WSA) in 2018. She currently serves as Chair of the WSA Executive Committee and as an advisor to the Bioinformatics Program and Biology Department at Hood College. In 2019 she was promoted to senior scientist. [2]

Kearney's scientific focus areas include clinical research, microbiology, infectious diseases, and virology. Her areas of expertise include HIV drug resistance, HIV persistence, HIV residual viremia, HIV cure, HIV evolution, and HIV genetics. [2] In 2019, Kearney, Sean Patro, and colleagues, advanced the understanding of proviral integration sites in a host cell's DNA. Previously, scientists had not been able to link such sites with the populations of identical HIV proviruses that persist in patients on treatment. [4] [5]

Awards and honors

Kearney is the recipient of three Bench-to-Beside Awards, three NIH Intramural AIDS Targeted Antiviral Program Awards, and a U.S.–South Africa Initiative U01 Grant. Kearney was awarded the NIH Director's Award and NCI Group Award in 2012, the NCI Director's Award in 2015, and the CCR Group Award in 2016. Kearney received a 2019 NIH Director's Award as a member of the NIH Women Scientist Advisors (WSA) Executive Committee. Nominated by the NIH Office of the Director, the Executive Committee members received this team award for leadership of the WSA in promoting recruitment, retention, and recognition of women scientists and fair treatment with respect to salary and work environment. [2]  

Related Research Articles

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.

Douglas D. Richman is an American infectious diseases physician and medical virologist. Richman's work has focused on the HIV/AIDS pandemic, since its appearance in the early 1980s. His major contributions have been in the areas of treatment, drug resistance, and pathogenicity.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

Avindra "Avi" Nath, is a physician-scientist who specializes in neuroimmunology. Nath is a senior investigator, and intramural clinical director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in the United States. At NINDS, Nath also leads the Section of Infections of the Nervous System and plans to institute a translational research center. He previously served in several research and administrative positions at the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.

<span class="mw-page-title-main">John Coffin (scientist)</span> American virologist

John Coffin is an American virologist. Born in Boston, Massachusetts, raised in Schenectady, New York, Coffin is a professor of Molecular Biology and Microbiology at Tufts University in Boston. He is also the former director of the HIV Dynamics and Replication Program of the National Cancer Institute (NCI) and serves as special advisor to the director of the Center for Cancer Research at NCI. He is a member of the National Academy of Sciences and a recipient of American Cancer Society professorship. He has advised policy committees at the national level regarding retrovirus-related matters. Coffin was programme committee chair for the 18th Conference on Retroviruses and Opportunistic Infections in 2011.

William Douglas Figg is an American scientist (pharmacologist). He is a senior investigator (tenured) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland. He holds multiple titles within the NCI: Associate Director of the Center for Cancer Research, Co-Director of the Office of Translational Resources, Acting Branch Chief for the Genitourinary Malignancies Branch, Chief of the Clinical Pharmacology Program, and head of the Molecular Pharmacology Section. Dr. Figg is also the Co-Chief of Basic Research at the Center for Prostate Disease Research within the Walter Reed National Military Medical Center – Murtha Cancer Center in Bethesda, Maryland.

<span class="mw-page-title-main">NIH Intramural Research Program</span> Internal research program of the National Institutes of Health

The NIH Intramural Research Program (IRP) is the internal research program of the National Institutes of Health (NIH), known for its synergistic approach to biomedical science. With 1,200 Principal Investigators and over 4,000 Postdoctoral Fellows conducting basic, translational, and clinical research, the NIH Intramural Research Program is the largest biomedical research institution on earth. The unique funding environment of the IRP facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. With rigorous external reviews ensuring that only the most outstanding research secures funding, the IRP is responsible for many scientific accomplishments, including the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, and the creation of vaccines against hepatitis, Hemophilus influenzae (Hib), and human papillomavirus (HPV). In addition, the IRP has also produced or trained 21 Nobel Prize-winning scientists.

Deborah Persaud is a Guyanese-born American virologist who primarily works on HIV/AIDS at Johns Hopkins Children's Center.

<span class="mw-page-title-main">Lauren V. Wood</span> American allergist, immunologist

Lauren V. Wood is an American allergist, immunologist, and staff physician at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she has served as a principal investigator. She is known for conducting studies of vaccines for cancer, Human papillomavirus (HPV), Hepatitis C, and HIV especially for use with children, teens and young adults. She holds the rank of captain in the U.S. Public Health Service (PHS).

<span class="mw-page-title-main">Imogen Wright</span> South African software developer and bioinformatician

Imogen Wright is a South African software developer and bioinformatician. They are co-founder and CTO of Hyrax Biosciences, a software development company specialising in DNA analysis programs.

<span class="mw-page-title-main">Bonnie Mathieson</span> American biomedical scientist (1945-2018)

Bonnie Jean Mathieson was an American biomedical scientist and pioneer in HIV vaccine research. Mathieson worked at the National Institutes of Health (NIH) for 43 years. She played a fundamental role in NIH HIV/AIDS research, vaccine programs, and scientific policy.

<span class="mw-page-title-main">Sheue-yann Cheng</span> American molecular geneticist

Sheue-yann Cheng is an American molecular geneticist who pioneered the development of mouse models to understand the molecular basis of diseases due to mutations of thyroid hormone receptors. Cheng is a senior investigator at the National Cancer Institute and chief of the gene regulation section.

<span class="mw-page-title-main">Wei-Shau Hu</span> American geneticist

Wei-Shau Hu is an American geneticist specialized in HIV research, retroviral recombination, RNA packaging, and virus assembly. She is a senior investigator at the National Cancer Institute and head of the viral recombination section. She was an associate professor at West Virginia University.

<span class="mw-page-title-main">Ofelia Olivero</span> Argentine-American biologist

Ofelia Ana Olivero is an Argentine-American biologist specialized in HIV/AIDS and biomedical research. She pioneered the discovery of nucleoside analogs induced centrosomal amplification and aneuploidy while working as a senior staff scientist at the National Cancer Institute (NCI). In 2016, she became chief of the NCI diversity intramural workforce branch.

<span class="mw-page-title-main">Sara Sawyer</span>

Dr. Sara Lea Sawyer is a professor at the University of Colorado Boulder. She has received national and international prizes in virology. In 2011 she was as awarded the Presidential Early Career Award for Scientists and Engineers (PECASE) by President Barack Obama at the White House. She serves as a Senior Editor at the journal eLIFE, and as a government consultant on the topic of pandemic preparedness. In 2020, she co-founded Darwin Biosciences, an infectious disease diagnostics company located in Boulder, Colorado. Her research focuses on animal viruses that infect humans, including the emergent viruses HIV-1 and SARS-CoV-2.

<span class="mw-page-title-main">Jennifer Webster-Cyriaque</span> American dentist and immunologist

Jennifer Y. Webster-Cyriaque is an American dentist and immunologist specializing in the oral microbiome, salivary gland disease in patients with HIV, and cancer-causing viruses. She became the deputy director of the National Institute of Dental and Craniofacial Research in November 2020. Webster-Cyriaque was a faculty member at UNC Adams School of Dentistry and the UNC School of Medicine for 21 years.

<span class="mw-page-title-main">Aimée R. Kreimer</span>

Aimée Rebecca Kreimer is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.

<span class="mw-page-title-main">Sam Mbulaiteye</span>

Sam M. Mbulaiteye is a Ugandan physician-scientist and epidemiologist who researches Burkitt lymphoma. He is a senior investigator at the National Cancer Institute.

<span class="mw-page-title-main">Meredith Shiels</span>

Meredith Sarah Shiels is an American cancer epidemiologist who researches cancer risks in people with HIV. She is a senior investigator at the National Cancer Institute.

References

  1. Kearney, Mary (2001). "Determining the resistance profile of conocurvone, an early-stage inhibitor of HIV-1 replication". Hood College.
  2. 1 2 3 4 5 "Mary Kearney, Ph.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-04-11.
  3. Kearney, Mary (2008). HIV-1 evolution in recently infect patients (Thesis). OCLC   232639295.
  4. "Unlocking the key to HIV persistence". Center for Cancer Research. 2019-12-02. Retrieved 2020-04-11.
  5. Patro, Sean C.; Brandt, Leah D.; Bale, Michael J.; Halvas, Elias K.; Joseph, Kevin W.; Shao, Wei; Wu, Xiaolin; Guo, Shuang; Murrell, Ben; Wiegand, Ann; Spindler, Jonathan (2019-12-17). "Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors". Proceedings of the National Academy of Sciences. 116 (51): 25891–25899. Bibcode:2019PNAS..11625891P. doi: 10.1073/pnas.1910334116 . ISSN   0027-8424. PMC   6925994 . PMID   31776247.
PD-icon.svg This article incorporates public domain material from websites or documents of the National Institutes of Health.